abstract |
The present invention has an affinity to the 5-HT 6 receptor, novel tetrahydro represented by formula (I) useful in the treatment of various CNS disorders - about isoquinoline derivatives. In the above formula, J is selected from groups represented by formulas (a), (b) or (c), wherein (a) is group (i) and (b) is group (ii) , (C) are groups (iii). |